Birmingham biotech explores export opportunities in United States
A Birmingham healthcare company has made the first tentative steps towards opening up an export pipeline with the United States.
Based at the BioHub at Birmingham Research Park, Rightangled Diagnostics was one of six UK companies chosen to take part in a trade mission to Texas to showcase UK healthcare excellence.
The biotech company, which specialises in cardiac health, uses the latest advancements in biotechnology and genetic testing in order to help patients at an increased risk of developing certain heart conditions, and to help optimise their drug prescription.
During the mission, the firm visited leading health organisations across Texas in a bid to explore future partnering opportunities.
The unique visit offered the company an opportunity to connect with a variety of healthcare systems, R&D, buying and professional organisations at the highest levels.
The mission’s objective was to foster new relationships and adopt cutting-edge medical technologies into the state.
For Texan organisations it was considered an important opportunity to learn about and engage with the UK’s health system and understand how the market works.
The trade visit was organised by the Association of British Healthcare Industries (ABHI) and was supported by the UK government.
Founder and CEO of Rightangled Diagnostics, Abdullah Sabyah, said: “The trip was a great experience and an invaluable opportunity to meet and network with key decision-making individuals at the highest levels inside hospitals and prominent healthcare establishments in the state. It was great to showcase Birmingham and the UK in Texas.”
Texas is the seventh largest health economy in the world and has significant ambitions to be a global healthcare and life sciences player over the next decade.
The tour, which began in Houston, before moving to Dallas and Austin, was timed to coincide with the health track of South by Southwest (SXSW) thereby providing a further opportunity to meet with leaders in health and technology.